Latest KFF Health News Stories
Out-of-Pocket Pain From High-Deductible Plans Means Skimping on Care
High-deductible health insurance plans are increasingly common, and many more enrollees will likely need to choose such plans for the coming year. For those with chronic conditions like diabetes, the gamble can mean compromised care and long-term consequences.
Trump’s Idea for Health Accounts Has Been Tried. Millions of Patients Have Ended Up in Debt.
Republican calls to give Americans cash instead of health insurance subsidies double down on a decades-old strategy of moving people into high-deductible plans with health savings accounts.
Watch: What Do Republicans Really Want on Health Care?
On “What the Health? From KFF Health News,” distributed by WAMU, chief Washington correspondent and podcast host Julie Rovner sat down with Avik Roy, a GOP health policy adviser, to talk about how health care has evolved as a Republican Party issue.
Journalists Dig Into Maine HIV Outbreak and Ever-Closer End to Enhanced ACA Subsidies
KFF Health News journalists made the rounds on national media recently to discuss topical stories. Here’s a collection of their appearances.
Health Savings Accounts, Backed by GOP, Cover Fancy Saunas but Not Insurance Premiums
Health savings accounts can be used to cover medical expenses, tax-free. But while wealthier Americans are using them to pay for gym equipment, cedar ice baths, and hemlock saunas, poorer Americans can’t use them to pay their skyrocketing health insurance premiums.
Republicans Left Tribes Out of Their $50B Rural Fund. Now It’s Up to States To Share.
The Trump administration has championed its Rural Health Transformation Program as an investment in American families who have been left behind. But Native American tribes, whose communities have a significant presence in rural America and have some of the greatest health needs, are ineligible to apply directly for funding.
Aunque se reanuda SNAP, nuevas reglas laborales amenazan el acceso al programa de alimentos por años
Ahora, los estados deben cumplir con las nuevas reglas o enfrentar sanciones que podrían obligarlos a cubrir una parte mayor del costo del programa.
Un paquete de programas federales que por años han apoyado a mujeres y niños también está en la mira de Trump y de miembros de su gabinete, que dicen impulsar políticas pro natalidad.
Trump Wants Americans To Make More Babies. Critics Say His Policies Won’t Help Raise Them.
The administration’s embrace of the pronatalist movement often doesn’t include support for programs traditionally associated with the health and well-being of women, children, and families.
Even as SNAP Resumes, New Work Rules Threaten Access for Years To Come
Even as the federal government resumed funding the nation’s largest food assistance program, people risk losing access to the aid because of new rules.
Cómo decidir quiénes califican como “médicamente frágiles” según las reglas laborales de Medicaid
Ante la falta de directrices claras a nivel federal, los estados deben llegar a un acuerdo sobre cómo definir la fragilidad médica.
They Need a Ventilator To Stay Alive. Getting One Can Be a Nightmare.
Few nursing homes are set up to care for people needing help breathing with a ventilator because of ALS or other infirmities. Insurers often resist paying for ventilators at home, and innovative programs are now endangered by Medicaid cuts.
Medicaid Work Rules Exempt the ‘Medically Frail.’ Deciding Who Qualifies Is Tricky.
People on Medicaid deemed “medically frail” won’t need to meet new federal requirements that enrollees work 80 hours a month or perform another approved activity. But state officials are grappling with how to interpret who qualifies under the vague federal definition, which could affect millions.
Not Serious Enough To Turn on the Siren, Toddler’s 39-Mile Ambulance Ride Still Cost Over $9,000
After her son contracted a serious bacterial infection, an Ohio mother took the toddler to a nearby ER, and staffers there sent him to a children’s hospital in an ambulance. With no insurance, the family was hit with a $9,250 bill for the 40-minute ride.
Las quejas sobre deficiencias en Medicare Advantage son comunes, pero la supervisión federal es rara
Documentos gubernamentales obtenidos por KFF Health News muestran que la agencia que supervisa Medicare Advantage no se esfuerza por hacer cumplir normas vigentes.
What the Health? From KFF Health News: The GOP Circles the Wagons on ACA
Republicans are solidifying their opposition to extending pandemic-era subsidies for Affordable Care Act plans and seem to be coalescing around giving money directly to consumers to spend on health care. Meanwhile, HHS Secretary Robert F. Kennedy Jr. continues to leave his mark on the agency, with the CDC altering its website to suggest childhood vaccines could play a role in causing autism. Paige Winfield Cunningham of The Washington Post, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, and Shefali Luthra of The 19th join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews Avik Roy.
Complaints About Gaps in Medicare Advantage Networks Are Common. Federal Enforcement Is Rare.
Health systems drop out of Medicare Advantage plans all the time. Yet government documents obtained by KFF Health News show that federal regulators rarely warn plans that their networks of health providers are so skimpy they violate legal requirements.
Paciente evita la enfermedad de Lyme, pero recibe una factura sorpresa
El personal de una clínica de urgencias encontró otra garrapata en el cuerpo de Leah durante esa visita. Pero su aseguradora no quiso pagar por el tratamiento.
Ticked Off Over Preauthorization: Walk-In Patient Avoided Lyme Disease but Not a Surprise Bill
A Maine woman sought care at a clinic for a tick bite, then paid full price after her insurer denied coverage. Its reason? She didn’t have preapproval for the walk-in visit, even though testing later detected the pathogen that causes Lyme disease.
FDA’s Plan To Boost Biosimilar Drugs Could Stall at the Patent Office
Drug industry officials and analysts praised the FDA’s plans to streamline regulation of “biosimilars,” which are cheaper alternatives to biologic drugs. But patents that block such drugs from the U.S. market are getting harder to fight.
